Clinical Research Directory
Browse clinical research sites, groups, and studies.
Progesterone Primed Protocol Versus GnRH Antagonist in With PCO Undergoing ICSI
Sponsor: Beni-Suef University
Summary
To compare the effectiveness and safety of Progesterone Primed Ovarian Stimulation protocol (PPOS) using Dydrogestrone vs GnRH Antagonist Protocol in patients with expected high ovarian response undergoing ICSI cycle
Official title: Progesterone Primed Ovarian Stimulation Protocol (PPOS) VS GnRH Antagonist Protocol in Patients With Expected High Ovarian Response Undergoing ICSI Cycles: a Prospective Randomized Controlled Trial
Key Details
Gender
FEMALE
Age Range
20 Years - 40 Years
Study Type
INTERVENTIONAL
Enrollment
200
Start Date
2024-01-01
Completion Date
2026-04-05
Last Updated
2026-04-15
Healthy Volunteers
No
Interventions
Dydrogesterone Tablets
used for pituitary suppression in ICSI cycle
Cetrorelix
GnRH antagonist for pituitary suppression
Locations (1)
Beni-suef university Hospital
Banī Suwayf, Beni Suweif Governorate, Egypt